Table 2 Concentrations of glucose, insulin, glucagon, ghrelin, cholecystokinin (CCK), gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)
A | Gender effect | B | Protein-load effect | |||||
---|---|---|---|---|---|---|---|---|
Men | Women | Average | Control | 30 g protein | 70 g protein | Average | ||
60 min | ||||||||
Glucose | 4.9 ± 0.1 | 5.3 ± 0.1 | 5.5 ± 0.1a | 4.8 ± 0.2b | 5.0 ± 0.1b | |||
Insulin | 14.4 ± 1.5 | 4.0 ± 0.5a | 18.3 ± 2.3b | 20.9 ± 2.3b | ||||
Glucagon | 132 ± 12 | 96 ± 6 | 62 ± 3a | 134 ± 11b | 145 ± 12b | |||
Ghrelin | 1319 ± 180 | 1563 ± 236a | 1230 ± 179b | 1165 ± 130b | ||||
CCK | 6.3 ± 0.7 | 3.8 ± 0.3 | 3.5 ± 0.4a | 5.4 ± 0.6b | 6.2 ± 0.7b | |||
GIP | 24.2 ± 1.3 | 10 ± 1a | 31 ± 2b | 31 ± 2b | ||||
GLP-1 | 32.4 ± 3.1 | 21.4 ± 1.2 | 20 ± 2a | 29 ± 3b | 32 ± 2c | |||
180 min | ||||||||
Glucose | 5.0 ± 0.1 | 5.6 ± 0.2 | 5.3 ± 0.1 | |||||
Insulin | 5.1 ± 1.2 | 7.6 ± 0.7 | 3.6 ± 0.4a | 3.5 ± 0.4a | 11.9 ± 1.6b | |||
Glucagon | 99 ± 6 | 84 ± 6 | 59 ± 3a | 71 ± 7b | 145 ± 10c | |||
Ghrelin | 1477 ± 253 | 1713 ± 294a | 1633 ± 281a | 1085 ± 194b | ||||
CCK | 4.8 ± 0.5 | 3.1 ± 0.2 | 3.1 ± 0.3a | 3.4 ± 0.4a | 5.3 ± 0.4b | |||
GIP | 19.2 ± 1.2 | 7 ± 1a | 19 ± 1b | 31 ± 2c | ||||
GLP-1 | 35 ± 3 | 23 ± 1 | 20 ± 2a | 28 ± 2b | 38 ± 3c |
C | Interaction effect | |||||
---|---|---|---|---|---|---|
Men | Women | |||||
Control | 30 g protein | 70 g protein | Control | 30 g protein | 70 g protein | |
60 min | ||||||
Glucagon | 65 ± 5*,a | 154 ± 18*,b | 177 ± 15*,c | 58 ± 4a | 115 ± 10b | 114 ± 11b |
GLP-1 | 23.0 ± 2.4a | 35.0 ± 4.2b | 39.1 ± 3.0*,b | 17.2 ± 1.3a | 22.5 ± 1.4,b | 24.7 ± 1.4b |
180 min | ||||||
GIP | 7.6 ± 1.7*,a | 19.6 ± 1.8*,b | 31.8 ± 3.7c | 5.9 ± 1.9a | 21.4 ± 2.2b | 32.9 ± 3.9c |